UV light therapy for stubborn ringworm infections
Part of Infections, Skin clinical trials.
This trial tests if ultraviolet B (UVB) phototherapy can treat ringworm infections that have not improved with standard antifungal pills or have come back multiple times. It may be an option if you still have symptoms after taking terbinafine or itraconazole for at least 4 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have ringworm on your body or groin area that is confirmed by a doctor.
- You have taken antifungal pills like terbinafine or itraconazole for at least 4 weeks without success.
- You have not used any antifungal creams, pills, or steroid creams in the 2 weeks before starting the trial.
- You have had at least 2 relapses of ringworm in the past 6 months.
- A skin scraping test (KOH) and culture are positive for fungus at the start.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a stronger antifungal pill, voriconazole, for people whose ringworm (a fungal skin infection) hasn't cleared up after other treatments. It focuses on infections on the groin or trunk.
This study tests a new type of injection treatment for stubborn ringworm (tinea) infections that haven't improved with standard pills or creams. It aims to see if this immunotherapy works better for hard-to-treat cases, especially when the fungus might be resistant to usual medicines.
This trial compares two oral medications, fluconazole and itraconazole, to see which works better for treating ringworm that hasn't cleared up with topical creams. If you've had ringworm for at least 6 months despite using antifungal creams, this study may help find a more effective treatment.
This trial tests whether combining narrowband UVB light with topical steroids can help treat vitiligo, and looks at specific blood markers (CXCL11 and TEMRA) to see how the treatment affects the immune system. It may help patients with stable, non-segmental vitiligo who have not used systemic therapy in the last 3 months.
This trial tests if adding a second medication, isotretinoin, to the standard itraconazole treatment works faster or better for adults with ringworm on their body. It aims to find a safer and more effective way to treat this common fungal skin infection.
This trial tests whether combining hyperbaric oxygen therapy (breathing high-pressure oxygen in a chamber) with a specific type of ultraviolet light can help restore skin color in people with vitiligo. Vitiligo is a condition where patches of skin lose their pigment.
Hear when a new Fungal Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.